Top1000 Scholar

Scholarly Index

Anas Younes

Intercept Pharmaceuticals (United States); 41,523 total citations; 694 total publications; best world rank #32

Intercept Pharmaceuticals (United States)

41,523Total citations
694Total publications
101H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Lymphoma Diagnosis and TreatmentLifetime32US 1699.83
Chronic Lymphocytic Leukemia ResearchLifetime80US 5199.70
Histone Deacetylase Inhibitors ResearchLifetime41US 2999.46
Viral-associated cancers and disordersLifetime64US 3199.43
CNS Lymphoma Diagnosis and TreatmentLifetime34US 1899.49
CAR-T cell therapy researchLifetime211US 13499.27
Protein Degradation and InhibitorsLifetime112US 6798.98
Lung Cancer Treatments and MutationsLifetime627US 29798.66
Ubiquitin and proteasome pathwaysLifetime428US 21498.06
NF-κB Signaling PathwaysLifetime179US 8098.03
HER2/EGFR in Cancer ResearchLifetime358US 17098.44
Cytokine Signaling Pathways and InteractionsLifetime594US 26197.07
Cutaneous lymphoproliferative disorders researchLifetime310US 13297.01
Multiple Myeloma Research and TreatmentsLifetime649US 29196.85
Cell death mechanisms and regulationLifetime529US 21996.43
Toxin Mechanisms and ImmunotoxinsLifetime968US 45793.53
Heat shock proteins researchLifetime780US 33193.13
Methemoglobinemia and Tumor Lysis SyndromeLifetime438US 16276.17
Lymphoma Diagnosis and Treatment2021-2025740US 31593.89